Literature DB >> 24447181

Hemodynamic benefit of rest and exercise optimization of cardiac resynchronization therapy.

Tony Stanton1, Brian A Haluska, Rodel Leano, Thomas H Marwick.   

Abstract

The optimal method of cardiac resynchronization therapy (CRT) optimization is as yet unknown. We sought to investigate the responses of optimization at rest and on exercise. This 2 stage study involved 59 patients (age 65 ± 10, 75% male), who had all recently undergone successful CRT implantation. In the first stage, the 6-month response was compared between 30 individuals who underwent resting echocardiographic optimization of CRT [atrioventricular (AV delay) plus ventriculo-ventricular delays (VV delay)], compared with the 29 who did not. In the second stage, a subset of 37 patients from the original cohort were randomized (double-blind) to either resting echocardiographic optimization (n = 20) or exercise echocardiographic optimization (n = 17) and followed for a further 6 months. Clinical and echocardiographic data were collected at each stage. Patients undergoing rest optimization demonstrated improvement in almost all variables and significantly in B-type natriuretic peptide (BNP) in contrast to those without optimization. In a linear regression model, the only significant predictor of BNP change was whether an individual underwent resting optimization or not (β = 0.38, P = 0.04). In those undergoing resting optimization, the degree of change in AV delay was correlated with improvement in left ventricle (LV) end-diastolic volume (r(2)  = 0.33, P < 0.01). Optimization on exercise was associated with a significant decrease in 6-minute walk test compared to those randomized to rest optimization possibly due to inducing nonoptimization at rest. In conclusion, echocardiographic optimization of CRT at rest is superior to no optimization or optimization on exercise. Patients with the greatest change in AV delay to reach optimal may undergo greater LV remodeling.
© 2014, Wiley Periodicals, Inc.

Entities:  

Keywords:  brain natriuretic peptide; cardiac resynchronization therapy; echocardiography; heart failure; ventricular remodeling

Mesh:

Year:  2014        PMID: 24447181     DOI: 10.1111/echo.12506

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  3 in total

1.  Echocardiographic evaluation of cardiac dyssynchrony in patients with congestive heart failure.

Authors:  Chuan Qin; Li Zhang; Zi-Ming Zhang; Bin Wang; Zhou Ye; Yong Wang; Navin C Nanda; Ming-Xing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

2.  Echocardiography and cardiac resynchronisation therapy, friends or foes?

Authors:  W M van Everdingen; J C Schipper; J van 't Sant; K Ramdat Misier; M Meine; M J Cramer
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

3.  Vitamin D3 Reduces Tissue Damage and Oxidative Stress Caused by Exhaustive Exercise.

Authors:  Chun-Yen Ke; Fwu-Lin Yang; Wen-Tien Wu; Chen-Han Chung; Ru-Ping Lee; Wan-Ting Yang; Yi-Maun Subeq; Kuang-Wen Liao
Journal:  Int J Med Sci       Date:  2016-02-05       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.